Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19
Joep Schellens, PhD-student at Maastricht UMC+, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Thrombosis Research, adding:
”I’m excited to share my article, ‘Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the Maastricht cohort’, has been published in Thrombosis Research.
This publication outlines the influence of dexamethasone and tocilizumab treatment on coagulation and fibrinolysis in COVID-19 ICU patients.
Many thanks to my co-authors for their valuable contributions to this work!”
Title: Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort
Authors: Joep Schellens, Magdolna Nagy, Anne-Marije Hulshof, Frank van Rosmalen, René van Oerle, Thijs T.W. van Herpt, Teba Alnima, Mark M.G. Mulder, Dave Hellenbrand, Hugo ten Cate, Rob G.H. Driessen, Jan-Willem E.M. Sels, Iwan C.C. van der Horst, Yvonne M.C. Henskens, Bas C.T. van Bussel, Henri M.H. Spronk on behalf of the Dutch Covid and Thrombosis Coalition

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver